Wednesday, March 25, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Analysis

Meta Shares Under Pressure Following Critical Report

Felix Baarz by Felix Baarz
December 16, 2025
in Analysis, E-Commerce, Nasdaq, Tech & Software
0
Meta Stock
0
SHARES
30
VIEWS
Share on FacebookShare on Twitter

A new investigative report has cast a harsh light on Meta’s advertising practices, sending its shares lower and raising significant questions about its revenue priorities. The findings center on the company’s handling of advertisements from China, suggesting a potential conflict between profit motives and user safety.

The Core Allegations

The sell-off was triggered by a Reuters special report published on Monday, which cites internal company documents. The investigation alleges that Meta was aware of substantial risks from fraudulent advertisements originating in China but continued to derive significant revenue from them.

Key data points from the report include:

  • Chinese advertisers reportedly contributed over $18 billion to Meta’s revenue in 2024, accounting for more than 10% of its global total.
  • Internal estimates indicated that approximately 19% of this revenue—equating to more than $3 billion—was linked to ads associated with scams, illegal gambling, and other prohibited products.
  • A specialized China anti-fraud team had successfully reduced the volume of problematic ads in early 2024. However, this stricter enforcement was reportedly halted following intervention from CEO Mark Zuckerberg and an internal shift in “Integrity Strategy.”
  • Subsequently, the China-focused team was dissolved and restrictions on new Chinese advertising agencies were lifted, despite internal warnings of increasing harm to users globally.
  • Internal communications reportedly noted that the revenue loss from aggressive fraud prevention was “too high,” leading to a shift toward softer measures.

The market’s reaction reflects deep concerns over potential regulatory fallout and reputational damage. The stock remains under pressure, closing at 551 euros in the latest session. This places it roughly 22% below its 52-week high, though still notably above the low marked in April.

A Dual Burden: Dividends and Scrutiny

Beyond the substantive allegations, a technical factor also weighed on the share price this week. Meta began trading ex-dividend on Monday, following an increase in its quarterly payout to $0.525 per share.

Shareholders on the register at Monday’s close will receive the payment later this month. While the theoretical dividend adjustment explains a minor portion of the price movement, the dominant driver is clearly the selling pressure ignited by the Reuters investigation.

Should investors sell immediately? Or is it worth buying Meta?

Highlighting a Strategic Vulnerability

The situation underscores Meta’s growing, yet complex, dependence on the Chinese advertising market. While its core platforms like Facebook and Instagram are blocked within China, businesses from the country heavily utilize Meta’s services to reach international customers.

The internal estimate that nearly $3 billion in revenue may be tied to “scam” advertising adds a serious political dimension. In the United States, senators including Josh Hawley and Richard Blumenthal have previously called for investigations into Meta’s ad practices. The newly published report, with its concrete financial figures, is likely to fuel further regulatory and political initiatives.

Simultaneously, the $18 billion figure from China highlights this market’s outsized role in Meta’s growth, comparable in scale to entire geographic regions. For management, this creates a tangible tension between pursuing growth, managing compliance costs, and upholding user protection.

Looking Ahead: Regulatory Risk and Financial Transparency

In the coming weeks, investor attention will likely focus on potential responses from U.S. authorities. Should the Reuters findings prompt a formal inquiry by bodies like the FTC or SEC, the issue of “scam ads from China” could evolve into a persistent overhang for the stock.

From a chart perspective, the price is currently testing support levels as the market digests both the dividend adjustment and the reputational concerns. Two immediate next steps will be crucial. First, whether Meta issues a detailed public response to the allegations, particularly regarding the reported dissolution of its China anti-fraud team. Second, how management addresses the sustainability of its Chinese advertising revenue during the upcoming fourth-quarter earnings report, as this revenue segment is now squarely in the spotlight for investors.

Ad

Meta Stock: Buy or Sell?! New Meta Analysis from March 25 delivers the answer:

The latest Meta figures speak for themselves: Urgent action needed for Meta investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from March 25.

Meta: Buy or sell? Read more here...

Tags: META
Felix Baarz

Felix Baarz

My name is Felix Baarz, and I look back on over fifteen years of experience as a business journalist. I have always been fascinated by the mechanisms and dynamics of global financial markets as well as the complex economic and political interconnections that shape our world. With this passion, I have made a name for myself as an expert on international financial markets and dedicate myself with great commitment to making even the most complex topics understandable and accessible to my readers. My roots lie in Cologne, where I was born and raised. Early on, my curiosity about economic topics and international developments sparked my interest in journalism. After completing my studies, I began my career as a business editor at a respected German trade publication. Here I laid the foundation for my professional career, but my curiosity soon drew me out into the wider world. A turning point in my life was moving to New York, where I lived for six years and gained insight into leading media houses. In this vibrant metropolis, I was able to report firsthand from the heart of the global financial world. From daily developments on Wall Street to major economic policy decisions that make waves worldwide, I had the opportunity to write about central topics that move people and markets alike. This time shaped my perspective and sharpened my view of global interconnections.

Related Posts

Coherent Stock
AI & Quantum Computing

Coherent Stock Accelerates Toward New Highs on Key Breakthroughs

March 25, 2026
Corning Stock
AI & Quantum Computing

Corning’s Strategic Alliance with Meta Fuels Investor Confidence

March 25, 2026
Dell Stock
AI & Quantum Computing

Dell’s Quantum Security Push Amidst AI-Driven Growth

March 25, 2026
Next Post
Oracle Stock

Oracle Shares Slump as Market Skepticism Overrides AI Partnership Denials

NASDAQ 100 Stock

Tech Stocks Lead Market Decline as Bond Yields Climb

Walt Disney Stock

Disney Forges AI Alliance with OpenAI in Major Strategic Shift

Recommended

Finance_ People trading stocks

Analyst Upgrades QuinStreet Stock to Strong Buy with Increased Price Target

2 years ago
Trimble Stock

Trimble Stock: A Study in Contrasting Signals

7 months ago
Regency Centers Stock

Regency Centers Stock: Strong Dividend Hike Meets Market Skepticism

5 months ago
Cardinal Health Stock

Cardinal Health Shares Test Key Support Level Amid Sector Uncertainty

6 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Bloom Energy Broadcom Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Oracle Palantir PayPal Plug Power QuantumScape Realty Income Robinhood Rocket Lab USA Salesforce Strategy Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Gossamer Bio’s Pivotal FDA Meeting Looms in June 2026

Semiconductor Sector Faces Supply Chain Strain Amid Helium Shortage Concerns

Regulatory Scrutiny and Price Wars Threaten Fair Isaac’s Dominance

Figma Embraces Third-Party AI to Power Its Design Ecosystem

BioNano Genomics Stock: A Tale of Operational Gains and Revenue Headwinds

Humacyte Shares Hit Record Low Amid Capital Raise and Strategic Shifts

Trending

Coherent Stock
AI & Quantum Computing

Coherent Stock Accelerates Toward New Highs on Key Breakthroughs

by Kennethcix
March 25, 2026
0

Shares of Coherent surged this week, propelled by a landmark technological demonstration and significant corporate developments that...

Corning Stock

Corning’s Strategic Alliance with Meta Fuels Investor Confidence

March 25, 2026
Dell Stock

Dell’s Quantum Security Push Amidst AI-Driven Growth

March 25, 2026
Gossamer Bio Stock

Gossamer Bio’s Pivotal FDA Meeting Looms in June 2026

March 25, 2026
SOXX ETF Stock

Semiconductor Sector Faces Supply Chain Strain Amid Helium Shortage Concerns

March 25, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Coherent Stock Accelerates Toward New Highs on Key Breakthroughs
  • Corning’s Strategic Alliance with Meta Fuels Investor Confidence
  • Dell’s Quantum Security Push Amidst AI-Driven Growth

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com